The uptake of
glucose by cells closely reflects their energetic needs, and is becoming poorly regulated in many pathological conditions such as obesity, diabetes and cancer.
Not exact matches
In insulin - resistant bodies, the insulin and
glucose are repelled
by cells.
Rather than being used
by muscles for energy, the
glucose is redirected to fat
cells.
In other words, to nourish your
cells; vitamins, minerals, and
glucose are distributed
by water.
Agave and fructose in general does not spike blood sugar because it goes through your liver damaging it at the same time,
glucose is processed
by other
cells as well and thus it spikes your blood sugar, but fructose is processed just
by the liver.
Dunsby and colleagues used it to measure
glucose uptake, indicated
by a fluorescent biosensor, in multicellular kidney
cell spheroids.
The most promising chemical — sulforaphane, a naturally occurring compound found in cruciferous vegetables — tamped down
glucose production
by liver
cells growing in culture, and shifted liver gene expression away from a diseased state in diabetic rats.
Insulin is produced
by beta
cells to control
glucose levels in the blood.
«That observation is in line with the usual response of
cells to oxygen deprivation: they save on the consumption of oxygen
by converting
glucose to lactate instead of burning the
glucose.
In the pancreas, pancreatic beta
cells produce insulin, the hormone that provides fuel to the body's
cells by transporting
glucose.
Witness Avandia, a popular drug available since 1999 that lowers blood
glucose by making
cells more receptive to insulin — but that also, according to a report published in the New England Journal of Medicine in May, increases the risk of heart attack.
«Our stem
cell - based studies indicate that low - calorie sweeteners promote additional fat accumulation within
cells compared with
cells not exposed to these substances, in a dose - dependent fashion — meaning that as the dose of sucralose is increased more
cells showed increased fat droplet accumulation,» said Sabyasachi Sen, M.D., Associate Professor of Medicine at George Washington University in Washington, D.C. «This most likely occurs
by increasing
glucose entry into
cells through increased activity of genes called
glucose transporters.»
In type 1 diabetes, beta
cells in the pancreas that make insulin — the hormone that keeps our blood
glucose levels at a safe concentration — are destroyed
by the immune system.
To determine the age of the blood
cells, Higgins and his colleagues developed an equation that compares
glucose levels obtained
by the A1C test with another method called continuous
glucose monitoring.
This year her team discovered that sleep deprivation impedes the metabolism of
glucose, the sugar that powers the body, in fat
cells by a startling 30 percent.
In a recent study published in Angewandte Chemie International Edition, Associate Professor of Chemistry Wei Min's team developed a new
glucose analogue that can mimic the natural
glucose, and imaged its uptake as energy source
by living cancer
cells, neurons and tissues at the single
cell level.
«In the study we challenged the view that the age - dependent impairment in
glucose homeostasis is solely due to intrinsic, dysfunction of islet
cells, and hypothesized that it is instead affected
by systemic aging factors,» says first author Joana Almaca at the Diabetes Research Institute, University of Miami.
The reason for the reduced
glucose levels associated with bacterial meningitis was believed to be the need for
glucose as fuel
by infiltrating immune
cells in response to infection.
Researchers at Columbia University have reported a new approach to visualize
glucose uptake activity in single living
cells by light microscopy with minimum disturbance.
«We found that expression of
glucose transporters is completely shut down
by bacteria, leaving insufficient fuel for the immune
cells to fight off the infection,» said the study's first author, Subramanian Krishnan, PhD, of the Division of Infectious Diseases at CHLA.
Another method is for
cells to throttle back the processing of
glucose during lean times
by becoming insulin resistant, which blocks insulin from entering the
cell and in essence rations the supply of
glucose to last longer while also creating a powerful hunger impulse to drive people to find food.
Aware that cancers rewire their metabolism in ways that could change the epigenome and that distant metastases in pancreatic cancer naturally spread to organs fed
by a sugar - rich blood supply, the researchers wondered if the tumor
cells had altered the way they use the basic form of sugar,
glucose.
In addition, the researchers observed that adiponectin regulated the production of
glucose by rat liver
cells — suggesting that the hormone helps suppress the release of sugar stores.
A few years ago, Jihye Yun, then a graduate student at Johns Hopkins University in Baltimore, Maryland, found that colon cancer
cells whose growth is driven
by mutations in the gene KRAS or a less commonly mutated gene, BRAF, make unusually large amounts of a protein that transports
glucose across the
cell membrane.
Pancreatic beta
cells help maintain normal blood
glucose levels
by producing the hormone insulin — the master regulator of energy (
glucose).
Cantley's lab and collaborators found that large doses of vitamin C did indeed kill cultured colon cancer
cells with BRAF or KRAS mutations
by raising free radical levels, which in turn inactivate an enzyme needed to metabolize
glucose, depriving the
cells of energy.
But that production stops after a meal, when insulin is released
by the pancreas and performs its main task of removing sugar from the blood and shepherding the
glucose to multiple types of
cells that absorb it for energy.
By using the same cellular channels that funnel
glucose into a cancer
cell, 3BrPA can travel inside the cancer
cell and block its
glucose metabolic pathway, Geschwind says.
«Powering artificial hearts
by glucose biofuel
cells remains a long - term research objective.»
Past
glucose biofuel
cells kept the enzymes and redox mediators in close proximity to electrodes
by chemically bonding them on.
«Under no circumstances should it be concluded from our work that consumption of marijuana can be a way to cure diabetes,» Prof. Dobrzyn warns and explains: «The concentration of
glucose in the blood is determined
by the balance between the activities of alpha and beta
cells of the pancreas and insulin target tissues such as skeletal muscle and adipose tissue.
Unfortunately, the enzymes used in past
glucose biofuel
cells were not suitable for implants, because they either required highly acidic conditions to work or were inhibited
by a variety of ions found in the body.
These receptors determine the differentiation of
cell function and may increase the ability to produce insulin in response to
glucose by beta
cells.
«This was matched
by increased
glucose uptake for glycolysis, revealing that TCL1 promotes the metabolic switch in energy generation necessary for
cells to acquire pluripotency.»
From a theory dating back to the early 20th century
by Nobel Prize laureate Otto Warburg, it has been believed that, in order to support their growth, cancer
cells needed to increase their
glucose consumption, without using mitochondrial metabolism.
First, the researchers inhibited the tumour
cell mitochondria,
by restricting the cancer
cells only to
glucose as a fuel source; then, they took away their
glucose, effectively starving the cancer
cells to death.
GLUT1 appears here because these
cells have been taken over
by the virus, which increases demand for more
glucose to continue its infectious path.
Green fluorescent dyes in this microscopic view mark the presence of the
glucose transporter, GLUT1, on the surface of lymphoblastoid
cells which go on to form the lymphomas caused
by Epstein - Barr virus.
Throughout the day, the pancreas regulates the body's blood sugar levels, responding to an increase in
glucose after a meal
by secreting insulin, which helps
cells take up the sugar.
The
cells the researchers produced respond to
glucose by producing insulin, just as normal β
cells do.
An international team led
by metabolism experts Matthias Tschöp (Helmholtz Zentrum München / Technische Universität Müchen), Richard diMarchi (Indiana University) and Timo Müller (Helmholtz Zentrum München) report in the current issue of the journal
Cell that liver - specific delivery of the thyroid hormone T3 using glucagon corrects obesity,
glucose intolerance, fatty liver disease and atherosclerosis without causing adverse effects in other tissues.
Cells equipped with a gene whose activity is driven
by blue light were used to help diabetic mice control
glucose levels.
«Conversely, the necrotic part of the tumor is driven
by a distinct set of glioma stem
cells utilizing the BIM1 pathway and are characterized
by a mesenchymal, inflammatory
cell type dependent on
glucose metabolism in the absence of oxygen.
Mechanisms have been proposed
by which adipocyte hypertrophy may perturb adipocyte function in a
cell - autonomous fashion and thereby influence systemic
glucose and lipid metabolism (80 — 82).
Importantly, intraperitoneal inoculation of pancreatic homogenates containing IAPP aggregates into transgenic mice expressing human IAPP dramatically accelerates IAPP amyloid deposition, which was accompanied
by clinical abnormalities typical of T2D, including hyperglycemia, impaired
glucose tolerance, and a substantial reduction on β
cell number and mass.
Our findings demonstrate that induction of IAPP misfolding and aggregation
by administration of preformed IAPP - aggregated seeds leads to the development of marked T2D - like pathology, including severe hyperglycemia, impaired
glucose homeostasis, loss of β
cells, and changes in islets morphology.
Jonathan Schertzer, assistant professor of biochemistry and biomedical sciences and senior author of a paper published
by Cell Metabolism, explains it this way: «We know that gut bacteria, often called the microbiome, send inflammation signals that change how well insulin works to lower blood
glucose.
Follow - up work in
cell cultures
by King's lab showed that this defensive role for PKC - delta is triggered
by high levels of lipids rather than
glucose.
The researchers went on to demonstrate that SHP - 1 is reduced in mouse vascular smooth muscle
cells primarily
by the high levels of lipids in the blood associated with diabetes and related conditions, rather than the high levels of
glucose also present in those conditions.
ViaCyte is aiming to eliminate rigorous insulin treatment and
glucose testing
by engineering a type of stem
cell that produces insulin and other hormones that regulate sugar levels.